163
Participants
Start Date
September 30, 2011
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
GS-5885 tablet
GS-5885 tablet, 90 mg, QD
GS-9451 tablet
GS-9451 tablet, 200 mg QD
tegobuvir capsule
tegobuvir capsule, 30 mg BID
ribavirin tablet
ribavirin tablet (weight based: 1000 mg/day \<75 kg; 1200 mg/day ≥ 75 kg) divided twice daily (BID)
placebo matching ribavirin tablet
placebo matching ribavirin tablet, BID
placebo matching tegobuvir capsule
placebo matching tegobuvir capsule, BID
Weill Cornell Medical College, New York
University of Pennsylvania, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
Johns Hopkins University, Lutherville
Inova Fairfax Hospital Center for Liver Diseases, Falls Church
Digestive and Liver Disease Specialists, Norfolk
Bon Secours St. Mary's Hospital of Richmond, Inc., Newport News
University of North Carolina at Chapel Hill, Chapel Hill
Asheville Gastroenterology Associates, P.A., Asheville
Gastrointestinal Specialists of Georgia, PC, Marietta
University of Miami, Center for Liver Diseases, Miami
Gastro One, Germantown
Indianapolis Gastroenterology Research Foundation, Indianapolis
Henry Ford Health System, Novi
University of Kansas Medical Center, Kansas City
The North Texas Research Institute, Arlington
The University of Texas Health Sciences Center at Houston, Houston
The University of Texas Medical Branch, Galveston
Alamo Medical Research, San Antonio
University of Colorado, Aurora
Kaiser Permanente Medical Center, Los Angeles
Lightsource Medical, Los Angeles
California Liver Institute, Beverly Hills
Scripps Clinic, La Jolla
SCTI Research Foundation Liver Center, Coronado
Medical Associates Research Group, Inc., San Diego
Kaiser Permanente, San Diego
University of California, San Diego, La Jolla
California Pacific Medical Center, San Francisco
Virginia Mason Medical Center, Seattle
Orlando Immunology Center (ACH), Orlando
Massachusetts General Hospital, Boston
Beth Israel Deconess Medical Center, Boston
The Research Institute, Springfield
Saint Michael's Medical Center, Newark
University Gastroenterology, Providence
University of Calgary, Calgary
University Of Alberta Hospital, Edmonton
University of Alberta, Edmonton
Gordon & Leslie Diamond Health Care Centre, Vancouver
University of British Columbia, Vancouver
GIRI GI Research Institute, Vancouver
University of Manitoba, Winnipeg
London Health Sciences Centre, London
The Ottawa Hospital, Ottawa
Toronto General Hospital, University Health Network, Toronto
Toronto General Hospital, University Health Network, Toronto
Toronto Western Hospital, Toronto
Hospital Saint-Luc DU CHUM, Montreal
Clinical Research Puerto Rico Inc, San Juan
Lead Sponsor
Gilead Sciences
INDUSTRY